The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Wright Medical Group NV

Nasdaq: WMGI
Last

(U.S.) $24.74

Today's change+0.22 +0.90%
Updated August 26 4:00 PM EDT. Delayed by at least 15 minutes.
 

Wright Medical Group NV

Nasdaq: WMGI
Last

(U.S.) $24.74

Today's change+0.22 +0.90%
Updated August 26 4:00 PM EDT. Delayed by at least 15 minutes.

Wright Medical Group NV up (U.S.)$0.22

Wright Medical Group NV closed up Friday by (U.S.)$0.22 or 0.90% to (U.S.)$24.74. This security is unchanged over the last five days and the last 52 weeks. This security has underperformed the S&P 500 by 2.72% during the last year.

Key company metrics

  • Open(U.S.) $24.58
  • Previous close(U.S.) $24.52
  • High(U.S.) $25.00
  • Low(U.S.) $24.45
  • Bid / Ask-- / --
  • YTD % change+2.32%
  • Volume634,338
  • Average volume (10-day)1,003,519
  • Average volume (1-month)1,380,950
  • Average volume (3-month)1,502,385
  • 52-week range(U.S.) $15.02 to (U.S.) $25.50
  • Beta1.21
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$2.92
Updated August 26 4:00 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
-52.40%

Wright Medical Group NV has a net profit margin of -52.40%. Besides being negative, it is also below the industry average and implies that this company is not effective at turning revenues into bottom line profit.
Company Books

S&P TSX0.06%Sector:HealthcareIndustry:Medical Equipment, Supplies & Distribution
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2016Q1/2016Q4/2015Q3/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 26, 201606/26/2016Mar 27, 201603/27/2016Dec 27, 201512/27/2015Sep 27, 201509/27/2015
Revenue17116916975
Total other revenue--------
Total revenue17116916975
Gross profit12212310559
Total cost of revenue49476416
Total operating expense20520034083
Selling / general / administrative13613525555
Research & development1212235
Depreciation / amortization7654
Interest expense (income), net operating--------
Unusual expense (income)-----73
Other operating expenses, total--------
Operating income-34-31-171-9
Interest income (expense), net non-operating-13-12-37-1
Gain (loss) on sale of assets--------
Other--------
Income before tax-45-41-219-10
Income after tax-42-40-213-11
Income tax, total-3-1-61
Net income-229-48-273-11
Total adjustments to net income--------
Net income before extra. items-42-40-213-11
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-42-40-213-11
Inc. avail. to common incl. extra. items-229-48-273-11
Diluted net income-229-48-273-11
Dilution adjustment--------
Diluted weighted average shares10310311249
Diluted EPS excluding extraordinary itemsvalue per share-0.41-0.39-1.90-0.22
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share-0.41-0.39-1.94-0.18